El-Meligui YM - Search Results

1

Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.

Abdellateif MS, Hassan NM, Kamel MM, El-Meligui YM. Abdellateif MS, et al. Among authors: el meligui ym. Oncol Res. 2024 Feb 6;32(3):577-584. doi: 10.32604/or.2023.043026. eCollection 2024. Oncol Res. 2024. PMID: 38361758 Free PMC article.

2

Genetic Polymorphism Study of IDH 1/2 and TET2 Genes in Acute Myeloid leukemia Patients.

Atef M, Shafik NF, H A Hassan N, Allam RM, El-Meligui YM, Abdelaziz H. Atef M, et al. Among authors: el meligui ym. Asian Pac J Cancer Prev. 2023 Sep 1;24(9):3169-3182. doi: 10.31557/APJCP.2023.24.9.3169. Asian Pac J Cancer Prev. 2023. PMID: 37774069 Free PMC article.

3

Significance of platelets to lymphocytes and platelets to haemoglobin ratios in patients with systemic sclerosis.

Sarhan SA, El-Meligui YM. Sarhan SA, et al. Among authors: el meligui ym. Reumatol Clin (Engl Ed). 2023 Jan;19(1):12-17. doi: 10.1016/j.reumae.2021.11.005. Reumatol Clin (Engl Ed). 2023. PMID: 36603962 Free article.

4

Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients.

El-Meligui YM, Hassan NM, Kassem AB, Gouda NA, Mohanad M, Hamouda MA, Salahuddin A. El-Meligui YM, et al. Pharmgenomics Pers Med. 2022 Jun 25;15:663-674. doi: 10.2147/PGPM.S368640. eCollection 2022. Pharmgenomics Pers Med. 2022. PMID: 35782688 Free PMC article.

5

Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.

Fathalla LA, Kamal LM, Salaheldin O, Khalil MA, Kamel MM, Fahim HH, Abdel-Moneim YA, Abdulhakim JA, Abdel-Moneim AS, El-Meligui YM. Fathalla LA, et al. Among authors: el meligui ym. Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221096207. doi: 10.1177/03946320221096207. Int J Immunopathol Pharmacol. 2022. PMID: 35622504 Free PMC article.

6

Prognostic Impact of Concurrent DNMT3A, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients.

Elrhman HAEA, El-Meligui YM, Elalawi SM. Elrhman HAEA, et al. Among authors: el meligui ym. Clin Lymphoma Myeloma Leuk. 2021 Dec;21(12):e960-e969. doi: 10.1016/j.clml.2021.07.011. Epub 2021 Jul 16. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34376373

7

Correlation Study on HLA-DR and CD117 (c-Kit) Expressions: Its Prognosis and Treatment Response in Acute Myeloid Leukemia Patients.

El-Meligui YM, Abd Elrhman HE, Salahuddin A, Hamouda MA, Kassem AB. El-Meligui YM, et al. Pharmgenomics Pers Med. 2021 Mar 30;14:381-393. doi: 10.2147/PGPM.S268986. eCollection 2021. Pharmgenomics Pers Med. 2021. PMID: 33833549 Free PMC article.

8

Combined Expression of CD34 and FLT3-Internal Tandem Duplication Mutation Predicts Poor Response to Treatment in Acute Myeloid Leukemia.

Abdellateif MS, Kassem AB, El-Meligui YM. Abdellateif MS, et al. Among authors: el meligui ym. Int J Gen Med. 2020 Oct 16;13:867-879. doi: 10.2147/IJGM.S276138. eCollection 2020. Int J Gen Med. 2020. PMID: 33116779 Free PMC article.

9

The Meningioma 1 (MN1) Gene is an Independent Poor Prognostic Factor in Adult Egyptian Acute Myeloid Leukemia Patients.

Shafik RE, Hassan NM, El Meligui YM, Shafik HE. Shafik RE, et al. Among authors: el meligui ym. Asian Pac J Cancer Prev. 2017 Mar 1;18(3):609-613. doi: 10.22034/APJCP.2017.18.3.609. Asian Pac J Cancer Prev. 2017. PMID: 28440611 Free PMC article.

10

FLT3 Internal Tandem Duplication Mutation, cMPL and CD34 Expressions Predict Low Survival in Acute Myeloid Leukemia Patients.

Ebrahim EK, Assem MM, Amin AI, Kamel MM, El Meligui YM, Metwally AM. Ebrahim EK, et al. Among authors: el meligui ym. Ann Clin Lab Sci. 2016 Dec;46(6):592-600. Ann Clin Lab Sci. 2016. PMID: 27993871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters